Nonmyeloablative allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors: a review.

[1]  J. Chell.  Hematopoietic Cell Donor Registries , 2007 .

[2]  R. Handgretinger,et al.  Feasibility and Outcome of Reduced‐Intensity Conditioning in Haploidentical Transplantation , 2007, Annals of the New York Academy of Sciences.

[3]  K. Sullivan,et al.  Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  L. Kanz,et al.  Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicity. , 2006, Experimental hematology.

[5]  T. Spitzer,et al.  Current status of haploidentical stem cell transplantation , 2006, British journal of haematology.

[6]  I. Kawase,et al.  Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  R. Krance,et al.  Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. , 2006, Blood.

[8]  D. Srivastava,et al.  CD3 Depleted Hematopoietic Peripheral Blood Stem Cell Grafts in Children with Refractory Hematologic Malignancies Undergoing Transplantation from Mismatched Related Donors. , 2005 .

[9]  S. Ogawa,et al.  In Vivo Alemtuzumab Enables Haploidentical Human Leukocyte Antigen-Mismatched Hematopoietic Stem-Cell Transplantation Without Ex Vivo Graft Manipulation , 2005, Transplantation.

[10]  T. Spitzer.  Haploidentical stem cell transplantation: the always present but overlooked donor. , 2005, Hematology. American Society of Hematology. Education Program.

[11]  H. Einsele,et al.  Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors , 2004, British journal of haematology.

[12]  R. Handgretinger,et al.  A one-step large-scale method for T- and B-cell depletion of mobilized PBSC for allogeneic transplantation. , 2004, Cytotherapy.

[13]  J. Kurtzberg,et al.  Unrelated umbilical cord blood transplantation in adult patients. , 2003, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  James Hope,et al.  Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies. , 2003, Transplantation.

[15]  H. Widner,et al.  Induction of operational tolerance to discordant dopaminergic porcine xenografts1 , 2003, Transplantation.

[16]  M. Leffell,et al.  Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[17]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[18]  F. Claas,et al.  Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. , 2002, Blood.

[19]  P. Henslee-Downey,et al.  Allogeneic transplantation across major HLA barriers. , 2001, Best practice & research. Clinical haematology.

[20]  M. Martelli,et al.  Haploidentical stem cell transplantation in leukemia. , 2001, Blood reviews.

[21]  J. Wagner,et al.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.

[22]  A. Gratwohl,et al.  Increased stem cell dose, as obtained using currently available technology, may not be sufficient for engraftment of haploidentical stem cell transplants , 2000, Bone Marrow Transplantation.

[23]  J. Sierra,et al.  Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience , 2000, Bone Marrow Transplantation.

[24]  J. Klein,et al.  Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. , 2000, The New England journal of medicine.

[25]  A. Nademanee,et al.  Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. , 2000, Blood.

[26]  C. Anasetti.  Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia , 2000, Leukemia.

[27]  ohn,et al.  The GRAFT-VERSUS-HOST DISEASE IN CHILDREN WHO HAVE RECEIVED A CORD-BLOOD OR BONE MARROW TRANSPLANT FROM AN HLA-IDENTICAL SIBLING , 2000 .

[28]  A. Nademanee,et al.  Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. , 2000, Blood.

[29]  T. Lion,et al.  Transplantation of highly purified peripheral blood CD34+ cells from HLA-mismatched parental donors in 14 children: evaluation of early monitoring of engraftment , 1999, Leukemia.

[30]  M. Sykes,et al.  Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen. , 1999, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[31]  S. Asano,et al.  Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor. , 1998, Blood.

[32]  A. Nagler,et al.  Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. , 1998, Blood.

[33]  J. Hansen,et al.  Hematopoietic stem cell transplants from unrelated donors , 1997, Immunological reviews.

[34]  D. Confer.  Unrelated marrow donor registries , 1997, Current opinion in hematology.

[35]  E. Milford,et al.  IMPACT OF RACIAL GENETIC POLYMORPHISM ON THE PROBABILITY OF FINDING AN HLA‐MATCHED DONOR , 1995, Transplantation.